Synthesis and adrenolytic activity of new propanolamines.

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Grazyna GroszekBarbara Filipek

Abstract

The synthesis of (2R,S)-1-(6-methoxy-4-(methoxymethyl)-1H-indol-5-yloxy)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol and (2R,S)-1-(4-methoxy-6-(methoxymethyl)-1H-indol-5-yloxy)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol is described. The compounds were tested for electrographic, antiarrhythmic, hypotensive, and spasmolytic activity, as well as for alpha(1)-, alpha(2)- and beta(1)-adrenoceptor binding affinity.

References

Jul 18, 1975·Archiv Für Dermatologische Forschung·L Szekeres
Mar 1, 1983·Circulation·R J HarimanN El-Sherif
Apr 18, 2001·Biological & Pharmaceutical Bulletin·A OrisadipeK Gamaniel
Mar 22, 2002·The Journal of Pharmacology and Experimental Therapeutics·Klaus PönickeOtto-Erich Brodde
May 1, 1965·Journal of Medicinal Chemistry·J AUGSTEINC R WORTHING
May 18, 2004·The American Journal of Cardiology·Brian Dulin, William T Abraham
Oct 31, 2006·American Heart Journal·Richard Shannon, Mohammad Chaudhry
Apr 25, 2007·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Guido GrassiRaffaella Dell'Oro
Apr 2, 2008·Bioorganic & Medicinal Chemistry·Kishor S JainMange Ram Yadav

❮ Previous
Next ❯

Methods Mentioned

BETA
column chromatography

Software Mentioned

Prism
GraphPAD

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.